These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 24524284)

  • 1. Cancer biomarker discovery: current status and future perspectives.
    Mäbert K; Cojoc M; Peitzsch C; Kurth I; Souchelnytskyi S; Dubrovska A
    Int J Radiat Biol; 2014 Aug; 90(8):659-77. PubMed ID: 24524284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in biomarker research for cancer detection.
    Srinivas PR; Kramer BS; Srivastava S
    Lancet Oncol; 2001 Nov; 2(11):698-704. PubMed ID: 11902541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of DNA methylation for cancer detection: promises and challenges.
    Zhu J; Yao X
    Int J Biochem Cell Biol; 2009 Jan; 41(1):147-54. PubMed ID: 18834953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome network medicine: innovation to overcome huge challenges in cancer therapy.
    Roukos DH
    Wiley Interdiscip Rev Syst Biol Med; 2014; 6(2):201-8. PubMed ID: 24318985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementing genomic medicine in pathology.
    Williams ES; Hegde M
    Adv Anat Pathol; 2013 Jul; 20(4):238-44. PubMed ID: 23752086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trastuzumab and beyond: sequencing cancer genomes and predicting molecular networks.
    Roukos DH
    Pharmacogenomics J; 2011 Apr; 11(2):81-92. PubMed ID: 20975737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances and current issues in single-cell sequencing of tumors.
    Sun HJ; Chen J; Ni B; Yang X; Wu YZ
    Cancer Lett; 2015 Aug; 365(1):1-10. PubMed ID: 26003306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive next-generation cancer genome sequencing in the era of targeted therapy and personalized oncology.
    Cronin M; Ross JS
    Biomark Med; 2011 Jun; 5(3):293-305. PubMed ID: 21657839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular markers for cancer prognosis and treatment: have we struck gold?
    Nowsheen S; Aziz K; Panayiotidis MI; Georgakilas AG
    Cancer Lett; 2012 Dec; 327(1-2):142-52. PubMed ID: 22120674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer omics: from regulatory networks to clinical outcomes.
    Tang B; Hsu PY; Huang TH; Jin VX
    Cancer Lett; 2013 Nov; 340(2):277-83. PubMed ID: 23201140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The power of NGS technologies to delineate the genome organization in cancer: from mutations to structural variations and epigenetic alterations.
    Schweiger MR; Kerick M; Timmermann B; Isau M
    Cancer Metastasis Rev; 2011 Jun; 30(2):199-210. PubMed ID: 21267768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics-driven cancer biomarker discovery: looking to the future.
    Simpson RJ; Bernhard OK; Greening DW; Moritz RL
    Curr Opin Chem Biol; 2008 Feb; 12(1):72-7. PubMed ID: 18295612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating biomarker panels for targeted therapy in brain tumors.
    Tanase C; Albulescu R; Codrici E; Popescu ID; Mihai S; Enciu AM; Cruceru ML; Popa AC; Neagu AI; Necula LG; Mambet C; Neagu M
    Future Oncol; 2015; 11(3):511-24. PubMed ID: 25241806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic biomarker development.
    Bock C
    Epigenomics; 2009 Oct; 1(1):99-110. PubMed ID: 22122639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic approaches to the discovery of cancer biomarkers for early detection and personalized medicine.
    Honda K; Ono M; Shitashige M; Masuda M; Kamita M; Miura N; Yamada T
    Jpn J Clin Oncol; 2013 Feb; 43(2):103-9. PubMed ID: 23248327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies.
    Kulasingam V; Diamandis EP
    Nat Clin Pract Oncol; 2008 Oct; 5(10):588-99. PubMed ID: 18695711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput SNP/CGH approaches for the analysis of genomic instability in colorectal cancer.
    Brenner BM; Rosenberg D
    Mutat Res; 2010 Nov; 693(1-2):46-52. PubMed ID: 20416328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological markers in lung cancer: A clinician's perspective.
    Tufman A; Huber RM
    Cancer Biomark; 2010; 6(3-4):123-35. PubMed ID: 20660959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic sequencing for cancer diagnosis and therapy.
    Wang L; Wheeler DA
    Annu Rev Med; 2014; 65():33-48. PubMed ID: 24274147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic profiling joins personalized cancer medicine.
    Heyn H; Méndez-González J; Esteller M
    Expert Rev Mol Diagn; 2013 Jun; 13(5):473-9. PubMed ID: 23782254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.